Year |
Citation |
Score |
2008 |
Hodge J, Bow JP, Plyler KS, Vemuri VK, Wisniecki A, Salamone JD, Makriyannis A, McLaughlin PJ. The cannabinoid CB1 receptor inverse agonist AM 251 and antagonist AM 4113 produce similar effects on the behavioral satiety sequence in rats. Behavioural Brain Research. 193: 298-305. PMID 18602425 DOI: 10.1016/J.Bbr.2008.06.010 |
0.724 |
|
2006 |
McLaughlin PJ, Qian L, Wood JT, Wisniecki A, Winston KM, Swezey LA, Ishiwari K, Betz AJ, Pandarinathan L, Xu W, Makriyannis A, Salamone JD. Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387. Pharmacology, Biochemistry, and Behavior. 83: 396-402. PMID 16616951 DOI: 10.1016/J.Pbb.2006.02.022 |
0.721 |
|
2005 |
Betz A, Ishiwari K, Wisniecki A, Huyn N, Salamone JD. Quetiapine (Seroquel) shows a pattern of behavioral effects similar to the atypical antipsychotics clozapine and olanzapine: studies with tremulous jaw movements in rats. Psychopharmacology. 179: 383-92. PMID 15619122 DOI: 10.1007/S00213-004-2046-9 |
0.749 |
|
2005 |
Salamone JD, Carlson BB, Rios C, Lentini E, Correa M, Wisniecki A, Betz A. Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of Parkinsonism: tremorolytic effects of pergolide, ropinirole and CY 208-243. Behavioural Brain Research. 156: 173-9. PMID 15582103 DOI: 10.1016/J.Bbr.2004.05.019 |
0.767 |
|
2004 |
Correa M, Wisniecki A, Betz A, Dobson DR, O'Neill MF, O'Neill MJ, Salamone JD. The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism. Behavioural Brain Research. 148: 47-54. PMID 14684247 DOI: 10.1016/S0166-4328(03)00178-5 |
0.78 |
|
2003 |
McLaughlin PJ, Winston K, Swezey L, Wisniecki A, Aberman J, Tardif DJ, Betz AJ, Ishiwari K, Makriyannis A, Salamone JD. The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats. Behavioural Pharmacology. 14: 583-8. PMID 14665975 DOI: 10.1097/00008877-200312000-00002 |
0.724 |
|
2003 |
Arizzi MN, Correa M, Betz AJ, Wisniecki A, Salamone JD. Behavioral effects of intraventricular injections of low doses of ethanol, acetaldehyde, and acetate in rats: studies with low and high rate operant schedules. Behavioural Brain Research. 147: 203-10. PMID 14659586 DOI: 10.1016/S0166-4328(03)00158-X |
0.714 |
|
2003 |
Wisniecki A, Correa M, Arizzi MN, Ishiwari K, Salamone JD. Motor effects of GABA(A) antagonism in globus pallidus: studies of locomotion and tremulous jaw movements in rats. Psychopharmacology. 170: 140-9. PMID 12827348 DOI: 10.1007/S00213-003-1521-Z |
0.768 |
|
2003 |
Correa M, Mingote S, Betz A, Wisniecki A, Salamone JD. Substantia nigra pars reticulata GABA is involved in the regulation of operant lever pressing: pharmacological and microdialysis studies. Neuroscience. 119: 759-66. PMID 12809696 DOI: 10.1016/S0306-4522(03)00117-9 |
0.708 |
|
2003 |
Carlson BB, Wisniecki A, Salamone JD. Local injections of the 5-hydroxytryptamine antagonist mianserin into substantia nigra pars reticulata block tremulous jaw movements in rats: studies with a putative model of Parkinsonian tremor. Psychopharmacology. 165: 229-37. PMID 12420151 DOI: 10.1007/S00213-002-1247-3 |
0.662 |
|
2002 |
Correa M, Carlson BB, Wisniecki A, Salamone JD. Nucleus accumbens dopamine and work requirements on interval schedules. Behavioural Brain Research. 137: 179-87. PMID 12445723 DOI: 10.1016/S0166-4328(02)00292-9 |
0.606 |
|
2001 |
Salamone JD, Wisniecki A, Carlson BB, Correa M. Nucleus accumbens dopamine depletions make animals highly sensitive to high fixed ratio requirements but do not impair primary food reinforcement. Neuroscience. 105: 863-70. PMID 11530224 DOI: 10.1016/S0306-4522(01)00249-4 |
0.634 |
|
2001 |
Salamone JD, Correa M, Carlson BB, Wisniecki A, Mayorga AJ, Nisenbaum E, Nisenbaum L, Felder C. Neostriatal muscarinic receptor subtypes involved in the generation of tremulous jaw movements in rodents implications for cholinergic involvement in parkinsonism. Life Sciences. 68: 2579-84. PMID 11392629 DOI: 10.1016/S0024-3205(01)01055-4 |
0.653 |
|
Show low-probability matches. |